Patents for C12R 1 - Micro-organisms (92,025)
12/2001
12/27/2001WO2001053525A3 Cell isolation method
12/27/2001WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity
12/27/2001WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
12/27/2001US20010056076 Treatment of acute lung injury and fibrosis with antagonists of alphavbeta6
12/27/2001US20010055806 Continuous cell-sheet structure consisting of monolayer of primary hepatocytes and the method of forming the sheet
12/27/2001US20010055795 Polyhydroxyalkanoate synthase and gene encoding the same enzyme
12/27/2001US20010055584 Improved nucleic acids encoding a chimeric glycosyltransferase
12/27/2001CA2414028A1 Low oxygen affinity mutant hemoglobins
12/27/2001CA2413870A1 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
12/26/2001CN1328466A Use of antifungal agents for treating scleroses
12/26/2001CN1076586C Mucosal competitive exclosion flora
12/25/2001US6333450 Methods of selecting plants having delayed or inhibited ripening or senescence
12/25/2001US6333186 Modified forms of Hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease: inhibitor complexes
12/25/2001US6333176 Enzymatic cleavage of c-terminal amino group from peptide amide, deamination with peptide amidase, incubation and inoculation
12/25/2001US6333175 Yield when disulfide-bonded proteins are secreted
12/25/2001US6333168 Cloning, expression and uses of dorsalin-1
12/25/2001US6333161 Assaying a test ligands ability to bind a central nervous system receptor by incubation the ligand with mutant cells that produce a kainate-binding excitatory amino acid receptor and determining the extent of binding
12/25/2001US6333030 Chimeric retrovirus/adenovirus system
12/25/2001CA2234164C Novel orthosomycins from micromonospora carbonacea
12/25/2001CA2220575C Soluble, active hepatitis c virus protease
12/25/2001CA2186775C Ribosome fraction and composition containing the same
12/25/2001CA2094027C Osteogenic peptides
12/20/2001WO2001096591A1 Process for producing carotenoid pigments
12/20/2001WO2001096577A1 Production of secreted polypeptides
12/20/2001WO2001096574A1 Novel enzyme gene and its expression product
12/20/2001WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same
12/20/2001WO2001096557A2 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
12/20/2001WO2001095709A1 Mouse showing neurofibril change due to senile dementia
12/20/2001WO2001046390A3 Method of inactivating microorganisms
12/20/2001WO2001044454A3 Root-specific promoter
12/20/2001WO2001031055A3 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays
12/20/2001WO2001029207A8 Antiuracil monoclonal antibody
12/20/2001WO1995026406A3 Riboflavin synthesis in fungi
12/20/2001US20010053544 Polyhydroxyalkanoate synthase and gene encoding the same enzyme
12/20/2001US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same
12/20/2001US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
12/20/2001DE10028837A1 Detecting infection by influenza A or B virus, comprises rapid analysis of a saliva sample, with detection of nucleic acid or nucleoprotein
12/20/2001DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence
12/20/2001CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
12/19/2001EP1164197A1 A method for mass production of taxol by elicitations
12/19/2001EP1164196A1 Retroviral vectors
12/19/2001EP1163522A1 Method for detecting superantigen activity in a biological sample
12/19/2001EP1163362A1 Device and method for microbial susceptibility testing
12/19/2001EP1163354A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
12/19/2001EP1163350A1 Polynucleotides for mutagenesis in fungus comprising a functional gene in magnaporthe and an impala tranposon
12/19/2001EP1163347A2 Zwittermicin a biosynthetic gene from bacillus cereus
12/19/2001EP1163344A1 Hyphal growth in fungi
12/19/2001EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001EP1163267A1 47 human secreted proteins
12/19/2001EP1163265A1 Immunogenic compounds
12/19/2001EP1163255A1 50 human secreted proteins
12/19/2001EP1162986A1 Lactobacillus strains preventing diarrhoea caused pathogenic bacteria
12/19/2001EP1001990A4 Protein that binds trail
12/19/2001EP0858510B1 Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products
12/19/2001EP0758387B1 Thymidine kinase mutants
12/19/2001EP0746624B1 Vector for liver-specific gene expression
12/19/2001EP0701570B1 Thermoresistant alpha-1-antitrypsin mutein
12/19/2001EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
12/19/2001CN1327476A Cleaning compositions comprising multily-substituted protease variants and amylase variants
12/19/2001CN1327449A Human cervical cancer 1 protooncogene and protein encoded therein
12/19/2001CN1076397C Process for preparing mycobacterium primers and probes
12/19/2001CN1076204C Recombinant coccidiosis vaccines
12/18/2001US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis
12/18/2001US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001US6331609 Fusion protein; for use in treatment of somatotropin defects
12/18/2001US6331521 Beta-1,3-glucan synthase inhibitors; pneumocystis pneumonia infection treatment; fungicides
12/18/2001US6331433 Human T cell leukemia cell line designated D1.1
12/18/2001US6331425 Nucleotide sequences coding enzymatic polypeptide; for use in the diagnosis and treatment of cancer, meningitis and urogenital disorders; for sequencing preferential oligosaccharides
12/18/2001US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein
12/18/2001US6331414 Preparation of human IGF via recombinant DNA technology
12/18/2001US6331410 Polynucleotides encoding a novel pyrR homolog
12/18/2001US6331403 Use of mCRP to slow cell growth and to promote maturation of cells
12/18/2001US6331301 Isolated dna sequences which encodes amino acid sequence in protein;
12/18/2001CA2215531C Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases
12/18/2001CA2209298C Mpl ligand analogs
12/18/2001CA2201762C Method for purifying keratinocyte growth factors
12/18/2001CA2088661C Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases
12/18/2001CA2045839C Cloned n-methylhydantoinase
12/13/2001WO2001094607A2 High level production of p-hydroxybenzoic acid in green plants
12/13/2001WO2001094548A2 Hy2 family of bilin reductases
12/13/2001WO2001059086A3 Methods and constructs for agrobacterium-mediated plant transformation
12/13/2001WO2001055103A3 Chimeric neuropeptide y receptors
12/13/2001WO2001030977A3 5r clavam producing microorganisms with deleted lat and cvm genes
12/13/2001WO1999061634A9 Method of producing thy a-strains of vibrio cholerae, such strains and their use
12/13/2001US20010051359 Genetic engineered protein
12/13/2001CA2412382A1 Hy2 family of bilin reductases
12/13/2001CA2411541A1 High level production of p-hydroxybenzoic acid in green plants
12/12/2001EP1162272A2 Generation of immune responses to prostate-specific antigen (SPA)
12/12/2001EP1162270A2 Phagemids coexpressing a surface receptor and a surface heterologous protein
12/12/2001EP1162269A1 Novel polypeptide
12/12/2001EP1162264A2 Chimeric hormone receptor
12/12/2001EP1162261A1 Continuous monolayer of primary hepatocytes
12/12/2001EP1161958A1 A method for the inactivation of viruses in biological liquids
12/12/2001EP1161954A1 Treatment of T cell mediated autoimmune disorders
12/12/2001EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction
12/12/2001EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
12/12/2001EP1161546A2 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
12/12/2001EP1161530A1 Protein for blocking platelet adhesion
12/12/2001EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection
12/12/2001EP1161447A1 50 human secreted proteins